Table 4 Cox regression analysis of factors that influence high BPV
Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age | 1.321 (1.112–1.572) | 0.017 | 1.178 (1.091–1.272) | 0.026 |
COVID-19 Severity | 1.465 (1.265–2.055) | 0.015 | 1.515 (1.332–2.389) | 0.003 |
CRP | 1.489 (0.986–0.993) | 0.012 | 1.323 (0.844–1.621) | 0.090 |
CAR | 1.758 (1.334–2.266) | 0.063 | 2.141 (1.118–3.198) | 0.002 |
Hypertension control status | 0.178 (0.114–0.192) | 0.000 | 0.128 (0.118–0.147) | 0.000 |
Antihypertensive drug | 0.237 (0.124–0.312) | 0.000 | 0.469 (0.292–0.721) | 0.000 |
WBC | 1.113 (1.011–2.551) | 0.044 | 2.562 (0.364–3.091) | 0.155 |
Sex (male) | 0.787 (0.621–1.435) | 0.787 | Not included | |
Albumin | 0.232 (0.146–1.058) | 0.454 | Not included | |
Procalcitonin | 1.046 (0.971–1.121) | 0.424 | Not included | |
SCr | 1.032 (0.542–1.932) | 0.263 | Not included | |
